Ignite Creation Date:
2024-05-06 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 12:50 PM
Study NCT ID:
NCT03611738
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-08
First Post:
2018-07-27
Brief Title:
Ceritinib Plus Docetaxel in ALK-Negative EGFR WT Advanced NSCLC
Sponsor:
Organization:
H Lee Moffitt Cancer Center and Research Institute